Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411

Clinical trial NCT04101357 · TERMINATED

Trial details

NCT number: NCT04101357
Sponsor: BioNTech SE
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Extensive-stage Small Cell Lung Cancer

Start date: 2020-06-19
Primary completion: 2024-01-19
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.